AZ Delta VZW, Roeselare
- Address
- lock Available on a paid plan
AZ Delta VZW - Trauma and Critical Care Research
AZ Delta VZW in Roeselare is a clinical research facility dedicated to advancing critical care medicine with a focus on improving outcomes for severely injured patients. The center participates in innovative therapeutic investigations aimed at reducing mortality and disability following traumatic events.
- Traumatic injury management and neuroprotection
- Critical care interventions for trauma patients
- Novel pharmacological approaches in emergency medicine
The research center's involvement in the EPO-TRAUMA study demonstrates its commitment to evaluating epoetin alfa therapy in critically ill trauma populations. By investigating strategies to reduce mortality and severe disability at six months post-injury, AZ Delta contributes valuable evidence to improve long-term outcomes for patients experiencing traumatic injuries.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1University College Dublin1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 307 other sites in Belgium
Therapeutic Area Benchmark — Belgium
Select a therapeutic area to compare against other sites in Belgium.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Belgium
Market Share
Country: Belgium
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in AZ Delta VZW, Roeselare
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Randomized, Double-Blind, Placebo-Controlled Trial of Epoetin Alfa in Mechanically Ventilated Critically Ill Patients with Traumatic Injury | University College Dublin | Phase III | Recruiting | Mar 2022 | — |
IMP list
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Epoetin Alfa | 1 | Unknown | 2022-03-29 | 2022-03-29 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.